Coronavirus Disease 2019 (COVID-19). COVID-19
Conditions
Interventions
Intervention 1: Intervention group: Oral Atorvastatin 40 mg for 5 days. Intervention 2: Control group: Routine Care.
Sponsors
Mazandaran University of Medical Sceinces
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Confirmed COVID-19 Diagnosis No prior Cardiovascular Disease No history of Statins use Chloroquine use No prior Kaletra usage No prior liver damage No prior myositis
Exclusion criteria
Exclusion criteria: Prior Kaletra Use Cardiovascular Disease Prior myositis Prior Liver damage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CRP level in Blood. Timepoint: At the beginning of the study at after 5 consecutive days. Method of measurement: Blood sampling and CRP measuring. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality during the study. Timepoint: from the beginning of the study until discharge. Method of measurement: Observing.;Duration of recovery. Timepoint: From the beginning of the study until discharge. Method of measurement: Observing and case file review. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactLotfollah Davoodi
Mazandaran University of Medical Sciences
Outcome results
None listed